Company Data
Clene Inc.
Ticker
CLNN
Current Price
$3.59 -4.52%
Market Cap
$32.2M
Price Target
Refer to Report
Volume
75.0K
52wk Range
$2.2801 - $6.96
Overview
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).